Rasna Therapeutics's total assets for Q were $26.18K, a decrease of -72.64% from the previous quarter. RASP total liabilities were $1.74M for the fiscal quarter, a -15.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.